| Dr Jennifer May Madrid Villacorta, MD | |
|
2500 N State St, Jackson, MS 39216-4500 | |
| (601) 984-5706 | |
| (601) 984-5733 |
| Full Name | Dr Jennifer May Madrid Villacorta |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 17 Years |
| Location | 2500 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215166798 | NPI | - | NPPES |
| 07674356 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 24333 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sta Home Health And Hospice | Clinton, MS | Home health agency |
| Kindred At Home -flowood | Flowood, MS | Home health agency |
| Mississippi Homecare Of Jackson | Jackson, MS | Home health agency |
| University Of Mississippi Med Center | Jackson, MS | Hospital |
| St Dominic-jackson Memorial Hospital | Jackson, MS | Hospital |
| Mississippi Baptist Medical Center | Jackson, MS | Hospital |
| Merit Health River Oaks | Flowood, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of Mississippi - University Of Mississippi Medical Center | 1850293036 | 804 |
News Archive
Wayne State University recently entered into an exclusive license agreement with TRImaran Pharma Inc. for a class of novel drugs developed at Wayne State University that aims to offer hope in the treatment of post-traumatic stress disorders (PTSD), depression, ADHD and other neurological disorders.
Recent studies showing that commonly used anesthetic agents can cause brain damage in animals don't prove that similar harmful effects occur in human newborns - and shouldn't affect current approaches to anesthesia in preterm and ill infants, according to a leading expert on pain management in newborns.
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical results presented at the AACR-IASLC (American Academy of Cancer Research – International Association for the Study of Lung Cancer) Joint Conference based on work done at Synta and at the Dana-Farber Cancer Institute in Boston showed that STA-9090, a potent, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated potent activity against 100% of all non-small cell lung cancer cell lines tested, including those with EGFR, HER2 or KRAS mutations including the EGFR T790 mutation that is present in roughly 50% of cases of erlotinib or gefitinib resistance.
After the Senate approved a House-passed spending package worth almost $450 billion on Sunday, the legislation, which "includes annual foreign aid packages," will go to President Barack Obama, Agence France-Presse reports. Obama is expected to sign the legislation (12/13).
John M. Boone, a UC Davis medical physicist and professor of radiology, has been awarded a $2.88 million grant from the National Cancer Institute to further develop and research computed tomography (CT) to detect breast cancer.
› Verified 3 days ago
| Entity Name | Mississippi Methodist Hospital & Rehabilitation Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1790711273 PECOS PAC ID: 8921912270 Enrollment ID: O20051005001042 |
News Archive
Wayne State University recently entered into an exclusive license agreement with TRImaran Pharma Inc. for a class of novel drugs developed at Wayne State University that aims to offer hope in the treatment of post-traumatic stress disorders (PTSD), depression, ADHD and other neurological disorders.
Recent studies showing that commonly used anesthetic agents can cause brain damage in animals don't prove that similar harmful effects occur in human newborns - and shouldn't affect current approaches to anesthesia in preterm and ill infants, according to a leading expert on pain management in newborns.
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical results presented at the AACR-IASLC (American Academy of Cancer Research – International Association for the Study of Lung Cancer) Joint Conference based on work done at Synta and at the Dana-Farber Cancer Institute in Boston showed that STA-9090, a potent, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated potent activity against 100% of all non-small cell lung cancer cell lines tested, including those with EGFR, HER2 or KRAS mutations including the EGFR T790 mutation that is present in roughly 50% of cases of erlotinib or gefitinib resistance.
After the Senate approved a House-passed spending package worth almost $450 billion on Sunday, the legislation, which "includes annual foreign aid packages," will go to President Barack Obama, Agence France-Presse reports. Obama is expected to sign the legislation (12/13).
John M. Boone, a UC Davis medical physicist and professor of radiology, has been awarded a $2.88 million grant from the National Cancer Institute to further develop and research computed tomography (CT) to detect breast cancer.
› Verified 3 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
Wayne State University recently entered into an exclusive license agreement with TRImaran Pharma Inc. for a class of novel drugs developed at Wayne State University that aims to offer hope in the treatment of post-traumatic stress disorders (PTSD), depression, ADHD and other neurological disorders.
Recent studies showing that commonly used anesthetic agents can cause brain damage in animals don't prove that similar harmful effects occur in human newborns - and shouldn't affect current approaches to anesthesia in preterm and ill infants, according to a leading expert on pain management in newborns.
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical results presented at the AACR-IASLC (American Academy of Cancer Research – International Association for the Study of Lung Cancer) Joint Conference based on work done at Synta and at the Dana-Farber Cancer Institute in Boston showed that STA-9090, a potent, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated potent activity against 100% of all non-small cell lung cancer cell lines tested, including those with EGFR, HER2 or KRAS mutations including the EGFR T790 mutation that is present in roughly 50% of cases of erlotinib or gefitinib resistance.
After the Senate approved a House-passed spending package worth almost $450 billion on Sunday, the legislation, which "includes annual foreign aid packages," will go to President Barack Obama, Agence France-Presse reports. Obama is expected to sign the legislation (12/13).
John M. Boone, a UC Davis medical physicist and professor of radiology, has been awarded a $2.88 million grant from the National Cancer Institute to further develop and research computed tomography (CT) to detect breast cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer May Madrid Villacorta, MD 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-5706 | Dr Jennifer May Madrid Villacorta, MD 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-5706 |
News Archive
Wayne State University recently entered into an exclusive license agreement with TRImaran Pharma Inc. for a class of novel drugs developed at Wayne State University that aims to offer hope in the treatment of post-traumatic stress disorders (PTSD), depression, ADHD and other neurological disorders.
Recent studies showing that commonly used anesthetic agents can cause brain damage in animals don't prove that similar harmful effects occur in human newborns - and shouldn't affect current approaches to anesthesia in preterm and ill infants, according to a leading expert on pain management in newborns.
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical results presented at the AACR-IASLC (American Academy of Cancer Research – International Association for the Study of Lung Cancer) Joint Conference based on work done at Synta and at the Dana-Farber Cancer Institute in Boston showed that STA-9090, a potent, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated potent activity against 100% of all non-small cell lung cancer cell lines tested, including those with EGFR, HER2 or KRAS mutations including the EGFR T790 mutation that is present in roughly 50% of cases of erlotinib or gefitinib resistance.
After the Senate approved a House-passed spending package worth almost $450 billion on Sunday, the legislation, which "includes annual foreign aid packages," will go to President Barack Obama, Agence France-Presse reports. Obama is expected to sign the legislation (12/13).
John M. Boone, a UC Davis medical physicist and professor of radiology, has been awarded a $2.88 million grant from the National Cancer Institute to further develop and research computed tomography (CT) to detect breast cancer.
› Verified 3 days ago
Raphael Corcoran Sneed, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-2940 | |
Alan Whitfield, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1325 E Fortification St, Jackson, MS 39202 Phone: 601-949-9110 Fax: 601-949-9113 | |
Dr. Amanda Leigh Witt, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Department Of Neurology, Jackson, MS 39216 Phone: 601-984-2940 | |
Abbie Joiner, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4607 Lindbergh Dr, Jackson, MS 39209 Phone: 601-203-6378 | |
Mr. Hyung Wook Kim, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2500 North State Street, University Rehabilitation Center, Jackson, MS 39216 Phone: 601-984-6525 | |
Mrs. Meredith Gore Warf, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1325 E Fortification St, Jackson, MS 39202 Phone: 601-354-4488 Fax: 601-949-9113 |